Research map: Phase I Trial and Pharmacokinetic Study of Berubicin (RTA 744) in Patients with Recurrent or Refractory High-Grade Gliomas

Back to the article

Papers in this map

  1. Cancer statistics, 2024 · Rebecca L. Siegel · 2024 · 9523 citations · Cited by this paper
  2. Cognitive dysfunction associated with cellular immunotherapy for cancer · 2026 · Related
  3. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial · Roger Stupp · 2009 · 7879 citations · Cited by this paper
  4. The molecular profile of gliomas in adolescents and young adults · 2026 · Related
  5. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma · Roger Stupp · 2017 · 2705 citations · Cited by this paper
  6. Immunogenomic Profiling Reveals Targets for Gene Therapy in Pediatric Brain Tumors · 2026 · Related
  7. Response criteria for phase II studies of supratentorial malignant glioma. · David R. Macdonald · 1990 · 2426 citations · Cited by this paper
  8. Emotional distress impairs immune checkpoint blockade efficacy in recurrent high-grade glioma: Insights from tumor in situ fluid analysis · 2026 · Related
  9. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016—2020 · Quinn T. Ostrom · 2023 · 1309 citations · Cited by this paper
  10. Mutational signature stratification of recurrent gliomas reveals distinct patterns of genomic traits · 2026 · Related
  11. Glioblastoma: clinical presentation, diagnosis, and management · Chris McKinnon · 2021 · 422 citations · Cited by this paper
  12. Emerging blood-based biomarkers for the detection of parenchymal brain metastasis: Current progress and future perspectives · 2026 · Related
  13. The NCI Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 is the new standard for oncology clinical trials · Alexander D. Colevas · 2004 · 114 citations · Cited by this paper
  14. ASL-based Exchange Time Mapping for Differentiation of High-Grade Glioma and Brain Metastases · 2026 · Related
  15. The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells · Tracy Ann Brooks · 2006 · 17 citations · Cited by this paper
  16. Disturbance of functional connectivity in patients with low grade glioma is associated with worse progression–free survival · 2026 · Related
  17. High-Dose Anthracycline Induction in Adult Acute Lymphocytic Leukemia · Giuseppe Todeschini · 2001 · 11 citations · Cited by this paper
  18. The Cell Surface Proteome of Malignant Peripheral Nerve Sheath Tumors Reveals Therapeutic Targets · 2026 · Related
  19. CTNI-74. PRIMARY RESULTS OF THE RANDOMIZED CLINICAL TRIAL OF BERUBICIN VS LOMUSTINE IN PATIENTS WITH GLIOBLASTOMA AFTER FAILURE OF PRIMARY THERAPY: DATA ANALYSIS AND FUTURE POSSIBILITIES · Mustafa Kashraw · 2025 · 2 citations · Cited by this paper
  20. Boron neutron capture therapy plus bevacizumab versus bevacizumab alone in recurrent glioblastoma: A propensity score–matched analysis · 2026 · Related

Source: OpenAlex (CC0)